title: Stent implantation for acute iliac artery occlusions: initial experience.
abstract: OBJECTIVE
  Treatment options for acute occlusion of the iliac arteries include surgical thrombectomy, surgical bypass, and endovascular interventions such as thrombolysis and mechanical thrombectomy with or without adjunctive angioplasty or stent implantation. Acute lesions are not usually treated by stent implantation for fear of distal embolism. The purpose of this study was to retrospectively review a single-center experience of primary iliac stent implantation for acute ischemia secondary to acute thrombosis.
  
  
  METHODS
  Between April 2004 and August 2005, seven patients (five men and two women; mean age, 69.9 y; range, 53-93 y) underwent iliac stent implantation for the acute onset (within 12 days before presentation) of ipsilateral ischemic symptoms. Diagnostic angiography revealed occlusion of the common and external iliac arteries (n = 3) or external iliac artery (n = 4). Patients with rest pain (n = 6) were treated with unfractionated heparin.
  
  
  RESULTS
  All acute occlusions were traversed by the guide wire with relative ease. Recanalization with stent implantation was successful in all cases without distal embolization. Five patients showed noticeable clinical improvement. Two elderly patients with isolated patent profunda segments with no demonstrable distal runoff vessels did not have long-term clinical improvement despite successful iliac recanalization.
  
  
  CONCLUSIONS
  This small case series suggests that primary stent implantation for acute iliac occlusions with a patent common femoral artery under intravenous heparin protection may be a reasonable endovascular alternative to thrombolysis for patients who cannot tolerate the time delay to achieve thrombolysis or who have contraindications to thrombolysis. The safety of this technique may be comparable to that of primary stent implantation for chronic occlusions, but larger series would be necessary to confirm this.
authors.affiliation: Sheffield Vascular Institute, Northern General Hospital, Sheffield, United Kingdom. berczi@hotmail.com
authors.forename: Viktor
authors.initials: V
authors.lastname: Berczi
authors.forename: Steven M
authors.initials: SM
authors.lastname: Thomas
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Turner
authors.forename: John R
authors.initials: JR
authors.lastname: Bottomley
authors.forename: Trevor J
authors.initials: TJ
authors.lastname: Cleveland
authors.forename: Peter A
authors.initials: PA
authors.lastname: Gaines
mesh_terms: D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000792:Angiography; D000925:Anticoagulants / Q000008:administration & dosage; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000628:therapy*; D002404:Catheterization; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007083:Iliac Artery; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015607:Stents; D016896:Treatment Outcome; D014654:Vascular Patency
chemical_list: D000925:Anticoagulants; D006493:Heparin